During the past decade, Faculdade de Medicina do ABC conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 29 clinical trials were completed, i.e. on average, 59.2% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 20 clinical trials were completed. i.e. 105.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Faculdade de Medicina do ABC" #1 sponsor was "Eli Lilly and Company" with 10 trials, followed by "Hoffmann-La Roche" with 9 trials sponsored, "Faculdade de Medicina do ABC" with 6 trials sponsored, "Pfizer" with 6 trials sponsored and "Takeda" with 6 trials sponsored. Other sponsors include 42 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Faculdade de Medicina do ABC" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "OCT Clinical Trials" with 3 trials as a collaborator, "Quintiles, Inc." with 3 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Faculdade de Medicina do ABC" are "Breast Neoplasms" (4 trials), "Crohn's Disease" (4 trials), "Rheumatoid Arthritis" (4 trials), "Breast Cancer" (3 trials) and "Colitis, Ulcerative" (3 trials). Many other conditions were trialed in "Faculdade de Medicina do ABC" in a lesser frequency.

Most popular intervention types in "Faculdade de Medicina do ABC" are "Drug" (73 trials), "Biological" (7 trials), "Other" (6 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (30 trials), "Baricitinib" (4 trials), "Abemaciclib" (3 trials), "GDC-0853" (3 trials) and "Atezolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Faculdade de Medicina do ABC" are 74 trials for "All" genders, 5 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Faculdade de Medicina do ABC". undefined are not yet recruiting, 11 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 45 completed trials in Faculdade de Medicina do ABC, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Faculdade de Medicina do ABC, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 62 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".

Faculdade de Medicina do ABC has several departments that took part in Clinical trials: "Centro de Estudos Multidisciplinar CEPES da Faculdade de Medicina do ABC" - 3 trials